awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37737800-C4A95988-2E37-4B43-9274-38559E41F34D
Q37737800-C4A95988-2E37-4B43-9274-38559E41F34D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37737800-C4A95988-2E37-4B43-9274-38559E41F34D
Posttransplant maintenance therapy in multiple myeloma: the changing landscape.
P2860
Q37737800-C4A95988-2E37-4B43-9274-38559E41F34D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37737800-C4A95988-2E37-4B43-9274-38559E41F34D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae1a8a3eef4b84d9721c9e16a3adfbb6ca450fec
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.